Ausgabe 2/2014
Inhalt (28 Artikel)
Glioblastoma treatment using perphenazine to block the subventricular zone’s tumor trophic functions
R. E. Kast, B. M. Ellingson, C. Marosi, M.-E. Halatsch
Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma
Denise Feierabend, Jan Walter, Susanne Grube, Christian Herbold, Christian Beetz, Rolf Kalff, Christian Ewald
18beta-Glycyrrhetinic acid induces apoptosis in pituitary adenoma cells via ROS/MAPKs-mediated pathway
Di Wang, Hei-Kiu Wong, Yi-Bin Feng, Zhang-Jin Zhang
Efficacy and selectivity of nilotinib on NF1-associated tumors in vitro
Wei Jiang, Claudia Schnabel, Melanie Spyra, Victor-F Mautner, Reinhard E. Friedrich, Christian Hagel, Paul W. Manley, Lan Kluwe
Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system
Rebekka Unland, Kornelius Kerl, Sabrina Schlosser, Nicole Farwick, Tanja Plagemann, Birigit Lechtape, Steven C. Clifford, Jonas H. Kreth, Joachim Gerss, Jörg Mühlisch, Günther H. S. Richter, Martin Hasselblatt, Michael C. Frühwald
The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma
Qi Yue, Xin Zhang, Hong-xing Ye, Yin Wang, Zun-guo Du, Yu Yao, Ying Mao
Retrospective evaluation of the outcomes of children with diffuse intrinsic pontine glioma treated with radiochemotherapy and valproic acid in a single center
Francisco Helder Cavalcante Felix, Orlandira Leite de Araujo, Karine Martins da Trindade, Nadia Mendonça Trompieri, Juvenia Bezerra Fontenele
Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas
Rakesh Kumar Gupta, Mehar C. Sharma, Vaishali Suri, Aanchal Kakkar, Manmohan Singh, Chitra Sarkar
Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers
Giuseppe Minniti, Antonella Arcella, Claudia Scaringi, Gaetano Lanzetta, Domenica Di Stefano, Stefania Scarpino, Andrea Pace, Felice Giangaspero, Mattia Falchetto Osti, Riccardo Maurizi Enrici
Measuring health-related quality of life in high-grade glioma patients at the end of life using a proxy-reported retrospective questionnaire
Eefje M. Sizoo, Linda Dirven, Jaap C. Reijneveld, Tjeerd J. Postma, Jan J. Heimans, Luc Deliens, H. Roeline W. Pasman, Martin J. B. Taphoorn
Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme
Eun Young Kim, Raphael Yechieli, Jin Koo Kim, Tom Mikkelsen, Steven N. Kalkanis, Jack Rock, Mark Rosenblum, Samuel Ryu
Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study
Takeo Uzuka, Kenichiro Asano, Toshio Sasajima, Kaori Sakurada, Toshihiro Kumabe, Takaaki Beppu, Masahiro Ichikawa, Chifumi Kitanaka, Hiroshi Aoki, Kiyoshi Saito, Kuniaki Ogasawara, Teiji Tominaga, Kazuo Mizoi, Hiroki Ohkuma, Yukihiko Fujii, Takamasa Kayama
Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
Rosa Nguyen, Kimberly Jett, Gordon J. Harris, Wenli Cai, Jan M. Friedman, Victor-Felix Mautner
A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients
An-an Yin, Sang Cai, Yu Dong, Lu-hua Zhang, Bo-lin Liu, Jin-xiang Cheng, Xiang Zhang
Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes
Rajiv Mangla, Daniel Thomas Ginat, Shervin Kamalian, Michael T. Milano, David N. Korones, Kevin A. Walter, Sven Ekholm
Quality of life research in neuro-oncology: a quantitative comparison
Elizabeth Klein, David Altshuler, Abhirami Hallock, Nicholas Szerlip
Vision specific quality of life in children with optic pathway gliomas
Robert A. Avery, Kristina K. Hardy
Incidence and prognostic value of multiple gene promoter methylations in gliomas
Longzhou Zhang, Maode Wang, Wei Wang, Jun Mo
Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastoma
Daniel E. Spratt, Michael Folkert, Zachary S. Zumsteg, Timothy A. Chan, Kathryn Beal, Philip H. Gutin, Elena Pentsova, Yoshiya Yamada
A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
Michelle Alonso-Basanta, Penny Fang, Amit Maity, Stephen M. Hahn, Robert A. Lustig, Jay F. Dorsey
Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI
Robert J. Harris, Susan Y. Bookheimer, Timothy F. Cloughesy, Hyun J. Kim, Whitney B. Pope, Albert Lai, Phioanh L. Nghiemphu, Linda M. Liau, Benjamin M. Ellingson
Skull base meningiomas: neurological outcome after microsurgical resection
Judith Scheitzach, Karl-Michael Schebesch, Alexander Brawanski, Martin A. Proescholdt
Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study
F. E. Froklage, L. J. Oosterbaan, E. M. Sizoo, M. de Groot, I. Bosma, E. Sanchez, L. Douw, J. J. Heimans, J. C. Reijneveld, F. J. Lagerwaard, J. Buter, B. M. J. Uitdehaag, M. Klein, T. J. Postma
Short-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institution
Haihui Jiang, Xiaohui Ren, Junmei Wang, Zhe Zhang, Wenqing Jia, Song Lin
Molecular analysis of diffuse intrinsic brainstem gliomas in adults
German Reyes-Botero, Marine Giry, Karima Mokhtari, Marianne Labussière, Ahmed Idbaih, Jean-Yves Delattre, Florence Laigle-Donadey, Marc Sanson
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry
Oscar Gallego, M. Cuatrecasas, M. Benavides, P. P. Segura, A. Berrocal, N. Erill, A. Colomer, M. J. Quintana, C. Balaña, M. Gil, A. Gallardo, P. Murata, A. Barnadas
Misinterpretation of statistical results and recurrent intracranial hemangiopericytoma
Da Li, Jun-Ting Zhang